Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study
Journal of Pharmacy & Pharmaceutical Sciences · 24.04.2021 · 24 · 191-199
DOI: 10.18433/jpps31456 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, online erschienen am 24.04.2021. Verfasst von Delaram Hossein Mostafa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical sciences branch, Islamic Azad University, Tehran, Iran. Die Arbeit wurde bisher 40-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Purpose
Prostaglandins play a pivotal role in modulating hair growth cycle. Prostaglandin F2α and prostaglandin E have stimulating and prostaglandin D has inhibitory effects on hair follicle. Cetirizine inhibits release of prostaglandin D2 and stimulates the release of prostaglandin E2. In the present study, the efficacy and safety of twice daily application of topical cetirizine 1% versus minoxidil 5% solutions for 16 weeks were compared in male androgenetic alopecia (AGA).
Methods
Forty men, aged 18 to 49 years, were randomly divided into two equal groups to apply either cetirizine 1% or minoxidil 5% solutions. The study was divided into two phases, a 16-week treatment phase either with cetirizine or minoxidil (anagen phase), followed by an 8-week drug-free (telogen phase) with a follow-up when patients used placebo. Efficacy outcomes included the change in total hair density, vellus and terminal hair density, hair diameter and the percentage of hair in anagen and telogen phases from baseline in 16 and 24 weeks.
Results
After 16 weeks, we observed a significant increase in total and vellus hair density in both minoxidil and cetirizine groups, but the improvement was much higher in the minoxidil group. The percentage of hair in the anagen phase also increased in both groups after 16 weeks of treatment, but then diminished after 8 weeks of placebo consumption. No significant adverse reactions associated with the administration of cetirizine solution were reported.
Conclusion
Cetirizine 1% solution was effective in hair growth without any complications for treatment of male AGA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmaceutical sciences branch, Islamic Azad University, Tehran, Iran.
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Legacy Healthcare SA, Epalinges, Switzerland.
Zitieren
APA
Hossein Mostafa, D., Samadi, A., Niknam, S., Nasrollahi, S. A., Guishard, A., & Firooz, A. (2021). Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. Journal of Pharmacy & Pharmaceutical Sciences, 24, 191-199. https://doi.org/10.18433/jpps31456
Vancouver
Hossein Mostafa D, Samadi A, Niknam S, Nasrollahi SA, Guishard A, Firooz A. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. Journal of Pharmacy & Pharmaceutical Sciences. 2021;24:191-199. doi:10.18433/jpps31456
BibTeX
@article{HosseinMostafa2021,
author = {Hossein Mostafa, Delaram and Samadi, Aniseh and Niknam, Somayeh and Nasrollahi, Saman Ahmad and Guishard, Alexandre and Firooz, Alireza},
title = {Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2021},
volume = {24},
pages = {191--199},
doi = {10.18433/jpps31456}
}
EUVIMED